Titelia

Funds holding LIXTE BIOTECHNOLOGY HOLDINGS INC

5 funds declare a position · 0 ETFs and 5 other funds · 282.4K $ · US5393193017

Each line carries its report date.

RankFundSharesValueWeight
1VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 49,479151.9K $0.00 %as of Mar 31, 2026 · Original filing
2Fidelity Extended Market Index Fund Fidelity Concord Street Trust 28,62082.7K $0.00 %as of Feb 28, 2026 · Original filing
3Fidelity Total Market Index Fund Fidelity Concord Street Trust 8,51624.6K $as of Feb 28, 2026 · Original filing
4Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 7,22820.9K $as of Feb 28, 2026 · Original filing
5Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 7752.2K $as of Feb 28, 2026 · Original filing

Institutional managers

12 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.

ManagerSharesValue
SCOTIA CAPITAL INC.283,162869.3K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC93,000285.5K $as of Mar 31, 2026
Federation des caisses Desjardins du Quebec64,487198K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC58,852180.7K $as of Mar 31, 2026
CITADEL ADVISORS LLC56,557173.6K $as of Mar 31, 2026
Ethos Financial Group, LLC24,80876.2K $as of Mar 31, 2026
XTX Topco Ltd23,44672K $as of Mar 31, 2026
STATE STREET CORP17,39653.4K $as of Mar 31, 2026
Atlas Legacy Advisors, LLC13,77142.3K $as of Mar 31, 2026
Tower Research Capital LLC (TRC)9733K $as of Mar 31, 2026
SBI Securities Co., Ltd.190583 $as of Mar 31, 2026
HRT FINANCIAL LP11,34634 $as of Mar 31, 2026